Low-dose HSP90 inhibitors DPB and AUY-922 repress apoptosis in HUVECs†
Abstract
In this study, we found that low-dose HSP90 inhibitors DPB and AUY-922 could unexpectedly restrain apoptosis in HUVECs. This hormesis was accompanied by the increase of p-AKT1. Our findings could have significant implications for the administration of HSP90 inhibitors in vascular diseases and cancer.